Reducing Cancer Care Costs by Comparative and Cost-Effectiveness Research (CER)
Well, it’s the day after Labor Day, time to resume our discussion of Bending the Cost Curve in Cancer Care. We’ve reached the end of the list, on ideas to reduce oncology costs put forth by Drs. Smith...
View ArticleHCR Law Requires Insurers to Cover Routine Care for Patients Participating in...
Something I learned at the MBCN conference is that the Patient Protection and Affordable Care Act of 2010 (PPACA, a.k.a. HCR), will require that private insurance companies cover the routine costs of...
View ArticleRegorafenib, an Experimental Pill Tested in Colon and Rectal Cancer Patients,...
Tomorrow the American Society of Clinical Oncology* will host its 9th annual GI Cancers Symposium. Bloomberg and the LA Times have already reported findings of a paper, still in abstract form, to be...
View ArticleNEJM Reports on 2 New Drugs for Hepatitis C
Last week’s NEJM delivered an intriguing, imperfect article on a new approach to treating hepatitis C (HCV). The paper’s careful title, Preliminary Study of Two Antiviral Agents for Hepatitis C...
View ArticleClik here to view.
NIH Sponsors New Website to Help Patients Understand Clinical Trials
This week the NIH launched a new website, NIH Clinical Research Trials and You. In a Feb 6 press release, NIH Director Dr. Francis S. Collins said “The ability to recruit the necessary number of...
View ArticleClik here to view.
The Outlier’s Message, and Evolutionary Science in Breast Cancer
This past week I read several attitude-altering articles about breast cancer. Kathy Rich, as featured in ‘O’ Magazine The first lesson, if I might call it that – in the way an oncologist can learn from...
View ArticleClik here to view.
Contemplating Breast Cancer, Beyond October 2012
It’s foggy today, October 3, ten years since the last mammogram I had and will ever need. I’ve been remiss in updating the blog. The reasons include family concerns and other projects. Meanwhile, I’ve...
View ArticleClik here to view.
Questions for ASCO – on Tamoxifen, ATLAS and aTTom
On Sunday in Chicago, oncologists and others at the plenary session of the annual ASCO meeting will be talking about an abstract that matters a lot to women with breast cancer. It’s a study on...
View ArticleClik here to view.
More on Mammography, Breast Cancer, Misleading Arguments, Emotion and Women’s...
It’s a holiday week. But when this morning’s paper delivered yet another op-ed by Dr. H. Gilbert Welch, citing (and breaking an embargo on) yet another, misleading and manipulative two-author analysis...
View ArticleClik here to view.
NIH to Drop Requirement for Websites Disclosing Researchers’ Ties to Industry
sunshine image Today’s word comes from Nature News that the NIH is dropping a proposed requirement for universities to disclose researchers’ financial ties to industry on websites. This is a loss for...
View Article
